HOME >> BIOLOGY >> NEWS
On life support: Future of science focus of lecture at UH

HOUSTON, Nov. 9, 2006 Former presidential adviser for science and technology policy, Neal Lane, is coming to the University of Houston to address the uncertain future of science in the United States.

As part of the annual UH Tenneco Distinguished Lecture Series, Lane, who also is the former director of the National Science Foundation, will speak in the main auditorium of the UH Science and Engineering Research and Classroom Complex at 5 p.m., Tuesday, Nov. 28. The lecture is free and open to the public.

In his talk, "U.S. Science Glorious Past, Uncertain Future," Lane will address three issues that will directly affect science: money, people and public understanding. He also will touch on three areas that he believes U.S. science and technology policy is in disarray: health and medical research; energy and environment; and space science and exploration. The lecture will conclude with thoughts about what might be done to address these concerns.

"The United States has enjoyed six decades of extraordinary scientific advancement made possible, in part, by enlightened policies to support basic research and encourage the use of new scientific knowledge and technologies to benefit the American people," Lane said. "But America indeed the world is in a very different state than it was at the end of World War II. The future of U.S. science is uncertain, and many of its vital signs are not good."

Widely regarded as a distinguished scientist and educator, Lane has written and presented extensively on topics that include theoretical, atomic and molecular physics and science and technology policy. He is the Malcolm Gillis University Professor at Rice University. He also holds appointments as a senior fellow of the James A. Baker III Institute for Public Policy, where he is engaged in science and technology policy, and in the Department of Physics and Astronomy.

Lane served in the federal government from 1998 to
'"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
9-Nov-2006


Page: 1 2

Related biology news :

1. Keck Futures Initiative announces grant recipients
2. The Origin, Evolution, and Future of Life on Earth
3. The Future of Chemical Plant Security one-day symposium, Monday, Aug. 29
4. National Academies Keck Futures Initiative to co-sponsor life engineering symposium
5. Future diabetes drugs may target new protein interaction
6. Future Vision 2005 to feature innovation in endoscopy
7. AFCYBER holds science and technology symposium
8. News tips from the Journal of Neuroscience
9. Neurosciences and music meet in Montreal
10. 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. News tips from the Journal of Neuroscience

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: life support Future science focus lecture

(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... -- Research and Markets ( ... "Capacitive Fingerprint Sensors Patent Landscape" report ... fingerprint sensing technology is the most reliable and ... developed. This patent landscape focuses on fingerprint sensors ... of capacitive fingerprint sensors is closely linked to ...
(Date:7/7/2015)... 7, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... mobile commerce market announces a revised version of one of its ... will air on CNBC in New York , ... and San Francisco metro areas.    ... Wocket,s ability to replace all the cards in your wallet and ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
(Date:7/29/2015)... , ... July 29, 2015 , ... The third Medical ... combination products , in particular, drug/device combinations. The current system received a score ... Initiative for Patient Centered Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ...
(Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... it has selected an optimized Erk inhibitor molecule ... the development of a new class of potential ... represents a prime target for therapeutic intervention in ... and survival benefits for B-Raf and Mek inhibitors. ...
(Date:7/29/2015)... ... July 29, 2015 , ... CSSi ... Silicon Valley-based CRO specializing in Clinical Trial Management. CSSi LifeSciences is specialized in ... core expertise of PRC Clinical is focused on Clinical Trial Management, Clinical Site ...
(Date:7/29/2015)... TX (PRWEB) , ... July 29, 2015 , ... Costello ... new levee system to protect the Orange County, Texas area from future storm ... multi-firm design team in determining several potential levee alignment alternatives for providing protection, Costello ...
Breaking Biology Technology:Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 2CSSi LifeSciences And PRC Clinical Join Forces To Offer Extended Clinical Trial Services 3Preventing Storm Surge Flooding in Houston 2
Cached News: